ICD-10-CM Billable Code

B38.7

Disseminated coccidioidomycosis

Clinical Classification Guidelines

Inclusion Terms

  • Generalized coccidioidomycosis

Medical Intelligence & Overview

Disseminated coccidioidomycosis is a serious fungal infection caused by the inhalation of spores from the Coccidioides species. It often begins in the lungs but can spread to other parts of the body, leading to a widespread or generalized infection. This condition is also known as generalized coccidioidomycosis and requires prompt diagnosis and management to prevent complications.

Causes & Symptoms

Clinical Causes: Inhalation of airborne spores from Coccidioides fungi present in soil, particularly in arid desert regions of the southwestern United States, Central and South America, and parts of Central Asia. Increased exposure due to activities that disturb soil, such as construction, farming, or excavation. People with weakened immune systems, such as those with HIV/AIDS, cancer, or on immunosuppressive therapy, are at higher risk of dissemination. Previous lung infection with coccidioidomycosis that has spread beyond the lungs.

Key Symptoms: Fever that may be persistent or recurrent Night sweats and chills Fatigue and weakness Weight loss Muscle or joint pain Skin lesions, which can include ulcers, nodules, or rashes Enlargement of lymph nodes Cough that may be persistent or productive Difficulty breathing or chest pain, especially if lung involvement persists

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation, laboratory testing, and imaging studies. Key components include: - **Serologic tests** to detect antibodies against Coccidioides fungi - **Culture of specimens** from affected tissues, blood, or bodily fluids - **Imaging techniques** like chest X-rays or CT scans to assess lung involvement and other affected areas - **Histopathological examination** of biopsied tissue to identify characteristic fungal structures Because disseminated disease affects multiple body systems, comprehensive assessment is crucial for accurate diagnosis.

Treatment Protocols: Management of disseminated coccidioidomycosis typically involves antifungal medications, with the choice and duration depending on disease severity and sites involved. Common treatments include: - **Long-term antifungal therapy** with agents such as fluconazole or itraconazole - **Amphotericin B** may be used in severe cases or when other treatments are ineffective - **Supportive care** to address specific symptoms or complications - **Monitoring and follow-up** to assess response to treatment and adjust therapy accordingly Early treatment is essential to control the spread of infection and reduce the risk of long-term complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B38.7 a billable ICD-10 code?
Yes, B38.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B38.7?
Clinical documentation must specify the nature of Disseminated coccidioidomycosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

coccidioidomycosis disseminated